As a typical autoimmune disease in neurology, myasthenia gravis (MG) imposes significant disease and healthcare burdens. In recent years, China has made remarkable progress in the diagnosis and treatment of MG, with the introduction of various innovative drugs providing highly effective therapeutic options. To further enhance specialized exchanges among experts in the field of neuroimmunology and promote standardized and precision-based MG treatment, the "Boundless Muscle Healing - 2025 Frontiers in Neuroimmunology Academic Symposium" was successfully held in Chengdu on September 7, 2025. Organized by the Chengdu High-Tech Medical Association, the symposium invited renowned domestic and international experts to deliver lectures. The content covered theoretical research on neurological diseases, clinical hot topics, and analysis of classic practical cases, demonstrating strong progressiveness, practicality, and operability.